Last updated on April 19, 2014 at 5:20 EDT

Latest Transcytosis Stories

2013-09-04 08:32:35

CALABASAS, Calif., Sept. 4, 2013 /PRNewswire/ -- ARMAGEN, a leader in the field of transporting therapeutics across the blood brain barrier (BBB) today announced the issuance of two additional patents by the U.S. Patent and Trademark Office (USPTO). Based on the work of Dr. William Pardridge, these new patents reinforce ARMAGEN's already dominant intellectual property position for the Company's novel platform for delivery of therapeutics across the BBB into the central nervous system...